Chordia researches and commercializes synthetic vaccines and immune therapies for cancer diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address: 26-1, Muraoka-Higashi 2-chome
City: Fujisawa
State: kanagawa prefecture
Zip: 251-0012
Country: JP
Chordia researches and commercializes synthetic vaccines and immune therapies for cancer diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2019 | Series B | 6 | $26.9M |
JAFCO Kyoto University Innovation Capital Mitsubishi UFJ Capital Nippon Venture Capital Shinsei Capital Partners SMBC Venture Capital JAFCO Kyoto University Innovation Capital Mitsubishi UFJ Capital Nippon Venture Capital Shinsei Capital Partners SMBC Venture Capital |
11/2017 | Series A | 5 | $10.8M |
Kyoto University Innovation Capital Mitsubishi UFJ Capital SMBC Venture Capital Sumitomo Mitsui Banking Corporation Takeda Kyoto University Innovation Capital Mitsubishi UFJ Capital SMBC Venture Capital Sumitomo Mitsui Banking Corporation Takeda |
5/2022 | Series C | $31.3M |
UTokyo Innovation Platform |
3/2019 | Series B | $27M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|